Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Open-label Placebos”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Not Yet RecruitingNCT07719023
What this trial is testing

Efficacy and Safety of AK3280 in Patients With Idiopathic Pulmonary Fibrosis

Who this might be right for
Idiopathic Pulmonary Fibrosis (IPF)
Shanghai Ark Biopharmaceutical Co., Ltd. 263
Testing effectiveness (Phase 2)Study completedNCT00210522
What this trial is testing

An Open-Label Extension Study of the Effectiveness and Safety of the Investigational Compound RWJ-333369 in Patients With Epilepsy

Who this might be right for
EpilepsyEpilepsies, Partial
SK Life Science, Inc. 421
Not applicableUnknownNCT05060523
What this trial is testing

To Study Effect of the Combination of Midodrine and Tolvaptan Versus Tolvaptan Alone in Patients With Severe Hyponatremia in Cirrhosis(TOLMINA Trial)

Who this might be right for
Liver Cirrhosis
Institute of Liver and Biliary Sciences, India 220
Testing effectiveness (Phase 2)Ended earlyNCT01824303
What this trial is testing

Safety, Tolerability and Efficacy Study of LiRIS® 400 mg in Women With Interstitial Cystitis

Who this might be right for
Interstitial Cystitis
Allergan 31
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07777549
What this trial is testing

The Safety and Efficacy of TRTL-913 in Healthy Volunteers (Part A) and in Adults With Tinnitus (Part B)

Who this might be right for
Tinnitus
Tortugas Neuroscience, Inc. 100
Large-scale testing (Phase 3)Study completedNCT05919823
What this trial is testing

Assess the Efficacy and Safety of KarXT in Acutely Psychotic Hospitalized Chinese Adult Subjects With DSM-5 Schizophrenia

Who this might be right for
Schizophrenia
Karuna Therapeutics, Inc., a Bristol Myers Squibb company 202
Testing effectiveness (Phase 2)Study completedNCT04009291
What this trial is testing

A Trial Investigating the Safety, Tolerability and Efficacy of TransCon PTH in Adults With Hypoparathyroidism

Who this might be right for
HypoparathyroidismEndocrine System DiseasesParathyroid Diseases
Ascendis Pharma A/S 59
Testing effectiveness (Phase 2)Study completedNCT02160782
What this trial is testing

Safety and Efficacy Study of LUM001 (Maralixibat) With a Drug Withdrawal Period in Participants With Alagille Syndrome (ALGS)

Who this might be right for
Alagille Syndrome
Mirum Pharmaceuticals, Inc. 31
Early research (Phase 1)Study completedNCT00259896
What this trial is testing

In-patient Study in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes MellitusDiabetes Mellitus, Type 2
GlaxoSmithKline 30
Large-scale testing (Phase 3)Looking for participantsNCT06930625
What this trial is testing

Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin Analogs

Who this might be right for
Acromegaly
Debiopharm International SA 119
Post-approval studies (Phase 4)Study completedNCT00678743
What this trial is testing

An Open-label Extension to Assess the Continued Efficacy of Omacor Plus Simvastatin

Who this might be right for
Dyslipidemias
Provident Clinical Research 17
Large-scale testing (Phase 3)Study completedNCT01457950
What this trial is testing

A Study in Korean Postmenopausal Women With Osteoporosis to Evaluate the Efficacy and Safety of Denosumab

Who this might be right for
Osteoporosis, Postmenopausal
GlaxoSmithKline 135
Early research (Phase 1)Study completedNCT02270918
What this trial is testing

Reversibility of Apixaban Anticoagulation With the Four Factor Prothrombin Complex Concentrate Kcentra

Who this might be right for
Thrombosis
Thomas Jefferson University 12
Early research (Phase 1)Study completedNCT02616861
What this trial is testing

Trial of IW-1973 (A Stimulator of Soluble Guanylate Cyclase (sGC)) in Healthy Volunteers

Who this might be right for
Healthy
Cyclerion Therapeutics 54
Large-scale testing (Phase 3)Study completedNCT00991757
What this trial is testing

An Open-Label Extension Study to Evaluate the Safety and Tolerability of RWJ 333369 as Adjunctive Therapy in Patients 16 Years and Older With Partial Onset Seizures.

Who this might be right for
EpilepsyComplex Partial SeizuresEpilepsy, Complex Partial+1 more
SK Life Science, Inc. 991
Testing effectiveness (Phase 2)Study completedNCT01704781
What this trial is testing

Vacc-4x + Lenalidomide vs. Vacc-4x +Placebo in HIV-1-infected Subjects on Antiretroviral Therapy (ART)

Who this might be right for
HIV-1 Infection
Bionor Immuno AS 36
Early research (Phase 1)Ended earlyNCT01829867
What this trial is testing

A Study With an Increased Dose Step in Patients That Have Previously Received Placebo or sNN0031.

Who this might be right for
Parkinson's Disease
Newron Sweden AB 5
Testing effectiveness (Phase 2)Study completedNCT03865732
What this trial is testing

Study of Adjunctive Ganaxolone Treatment in Female Children With Protocadherin 19 (PCDH19)-Related Epilepsy (Violet Study)

Who this might be right for
PCDH19-Related Epilepsy
Marinus Pharmaceuticals 29
Testing effectiveness (Phase 2)Ended earlyNCT00356681
What this trial is testing

AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast Cancer

Who this might be right for
Breast NeoplasmsBreast TumorsBreast Cancer+1 more
Amgen 282
Large-scale testing (Phase 3)Study completedNCT02347072
What this trial is testing

24-hour Lung Function in Subjects With Moderate to Very Severe COPD After Treatment With PT003, Open-Label Spiriva® Respimat® as an Active Control, and Placebo

Who this might be right for
COPD
Pearl Therapeutics, Inc. 80
Next Page